RNS - more skin in the game!!29 Jun 2021 15:20
Director/PDMR Shareholding
Tissue Regenix (AIM: TRX), the regenerative medical devices company, announces that on 25 June 2021, Brian Phillips, Non-executive director, acquired 2,886,671 Ordinary Shares in the Group at a price of 0.6 pence per share for a total consideration of £17,320.03.
As a result, Brian Phillips' beneficial interest in the Company is 6,322,756 Ordinary Shares, representing 0.09% of the total issued share capital.